| Sanofi launches inhaled insulin for diabetics |
jpourd14 |
Sep 10, 2015 11:46:11 AM |
| Sanofi launches inhaled insulin for diabetics |
jmarantidis |
Sep 10, 2015 4:37:05 AM |
| MannKind Corporation - FDA Accepts AFREZZA Complete Response Resubmission and Sets Target Action Date |
jmarantidis |
Sep 10, 2015 4:27:53 AM |
| The Impossible Made Possible |
jmarantidis |
Sep 10, 2015 4:21:38 AM |
| Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar |
jmarantidis |
Sep 10, 2015 4:16:19 AM |
| Press Announcements - FDA approves Afrezza to treat diabetes |
jmarantidis |
Sep 10, 2015 1:20:00 AM |
| Afrezza® (insulin human) Inhalation Powder |
jpourd14 |
Sep 10, 2015 12:53:55 AM |
| Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents - Full Text View - ClinicalTrials.gov |
jmarantidis |
Sep 10, 2015 12:49:27 AM |
| Psychological Insulin Resistance in Type 2 Diabetes Patients Regarding Oral Antidiabetes Treatment, Subcutaneous Insulin Injections, or Inhaled Insulin |
jmarantidis |
Sep 10, 2015 12:49:27 AM |
| A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus - Full Text View - ClinicalTrials.gov |
jmarantidis |
Sep 10, 2015 12:49:27 AM |
